Penses

Seoul, South Korea Founded: 2015 • Age: 11 yrs
3D cell analysis devices are developed for experimentation and diagnostics.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors 10 Brand Intelligence

About Penses

Penses is a company based in Seoul (South Korea) founded in 2015. Penses offers products and services including Cultivated Meat and Bio-Printing Technology. Penses operates in a competitive market with competitors including 10X Genomics, Mission Bio, Cellares, LUMICKS and Xcell Biosciences, among others.

  • Headquarter Seoul, South Korea
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Pangse Co., Ltd.
  • Jurisdiction Na, Maharashtra, India
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Penses

Penses offers a comprehensive portfolio of products and services, including Cultivated Meat and Bio-Printing Technology.

Primary

Lab-grown meat using bio-printing for sustainable and ethical consumption.

Advanced 3D printing for creating meat alternatives from animal cells.

Funding Insights of Penses

Investments & Acquisitions by Penses

Investments

Financial Statements - Penses

Penses Comparisons

+
Add Comparison
Available on Premium

Competitors of Penses

Penses operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 10X Genomics, Mission Bio, Cellares, LUMICKS and Xcell Biosciences, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Instrument systems for genomic research and sequencing libraries are developed.
domain founded_year HQ Location
Single-cell multi-omics platform is provided for genotypic and phenotypic analysis.
domain founded_year HQ Location
Medical devices for cell-based therapy manufacturing are produced.
domain founded_year HQ Location
Optical tweezers instruments for single-molecule analysis are manufactured.
domain founded_year HQ Location
Cell culture analysis devices for cancer research are developed.
domain founded_year HQ Location
Single-cell imaging platform developed via magnetic levitation technology.

Latest news on Penses

Frequently Asked Questions about Penses

Penses was founded in 2015.

Penses is headquartered in Seoul, South Korea.

The company was founded in 2015 in Seoul, South Korea, within the biotechnology sector. 3D cell analysis devices are produced for research and medical applications. Products such as the Vitarix W Bioprinter and a 3D arm spheroid model are offered, supporting tissue analysis, disease diagnosis, and 3D cell culture evaluation. Operations focus on innovative tools for cellular experimentation in laboratory settings.

Penses's top competitors include 10X Genomics, Mission Bio and Cellares.

Penses offers Cultivated Meat and Bio-Printing Technology.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available